Company page

Basilea Pharmaceutica Ag

Basilea Pharmaceutica AG, traded under the ticker BSLN, is a public company based in Switzerland with a market capitalization of approximately 786.57 million CHF. The company focuses on the development and commercialization of innovative therapies for the treatment of serious infections and cancer. Basilea is committed to advancing its pipeline of pharmaceutical products to address unmet medical needs.